Related Experiment Video
Updated: Jun 28, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hypertrophic cardiomyopathy: current understanding and treatment objectives
1Department of Pathology, Toronto General Hospital/University Health Network, Toronto, Canada.
Journal of Clinical Pathology
|October 22, 2008
Summary
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition caused by sarcomeric gene mutations. Early identification and research into genetic basis and therapies are crucial for optimizing patient care and preventing complications.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Hypertrophic cardiomyopathy (HCM) is increasingly understood as a genetic disorder.
- Mutations in cardiac sarcomeric genes are the primary cause of HCM.
- HCM presents significant risks including outflow tract obstruction, diastolic dysfunction, arrhythmias, stroke, infective endocarditis, and sudden cardiac death.
Purpose of the Study:
- To summarize the current understanding of hypertrophic cardiomyopathy (HCM).
- To provide insights into appropriate diagnostic investigations for HCM patients.
- To outline current treatment strategies for individuals with HCM.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on HCM.
- It discusses diagnostic and therapeutic approaches.
Main Results:
- HCM is a genetically determined cardiac disease.
- Early diagnosis and management are critical due to severe potential complications.
- Knowledge gaps remain regarding the full genetic basis and optimal therapeutic strategies.
Conclusions:
- Continued research into the genetic underpinnings of HCM is essential.
- Further assessment of therapeutic strategies is needed to improve patient outcomes.
- Optimizing patient care requires a comprehensive approach integrating genetic understanding, diagnostics, and treatment.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...